Mode
Home
Conditions Medications Drug Pipeline Weekly Digests
Text Size
Log in / Sign up
Home › Conditions › Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Incomplete nasolacrimal duct obstruction associated with severe upper eyelid meibomian gland loss
Rheumatology Cohort
Incomplete nasolacrimal duct obstruction associated with severe upper eyelid meibomian gland loss Incomplete blockage drives severe gland loss in postmenopausal women
This prospective cross-sectional study of 272 postmenopausal women found an association between incomplete nasolacrimal duct obstruction and…
A partial blockage in the tear duct causes much worse eye gland damage than a complete blockage in postmenopausal women.
Frontiers Apr 30, 2026
Perfluorohexyloctane Improves DED Symptoms in MGD Patients with Varied Baseline Severity
Drug Pipeline RCT
Perfluorohexyloctane Improves DED Symptoms in MGD Patients with Varied Baseline Severity Could new eye drops really ease dry eye symptoms for many patients?
Perfluorohexyloctane showed higher odds of improving EDS (OR: 2.25) and tCFS (OR: 2.21) in DED with MGD. Safety was consistent across severi…
New eye drops helped patients with severe dry eye feel better and improved their eye health more than saline, with few side effects.
Mar 28, 2026